Back to Search
LUIS MONTANER, MD
MD
Pediatrics Physician
NPI: 1306040423Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
2418(PR)
Research & Publications (20)
Structured treatment interruptions to control HIV-1 and limit drug exposure.
PMID 11286710·Trends Immunol·2001
6-review
Circulating monocytes in HIV-1-infected viremic subjects exhibit an antiapoptosis gene signature and virus- and host-mediated apoptosis resistance.
PMID 19299747·J Immunol·2009
8-other
Evidence of a decrease in CD4 recovery once back on antiretroviral therapy after sequential > or =6 weeks antiretroviral therapy interruptions.
PMID 19242262·J Acquir Immune Defic Syndr·2009
8-other
Delayed loss of control of plasma lipopolysaccharide levels after therapy interruption in chronically HIV-1-infected patients.
PMID 19114856·AIDS·2009
8-other
Retention of viability, cytotoxicity, and response to IL-2, IL-15, or IFN-alpha by human NK cells after CD107a degranulation.
PMID 19237639·J Leukoc Biol·2009
8-other
HIV type 1 viremia on ART is positively associated with polyclonal T cell proliferation in subjects with T cell IFN-gamma secretion levels comparable to those of uninfected subjects.
PMID 18788911·AIDS Res Hum Retroviruses·2008
8-other
DR5 activation of caspase-8 induces DC maturation and immune enhancement in vivo.
PMID 18087262·Mol Ther·2008
7-preclinical
Synthetic imidazoquinolines potently and broadly activate the cellular immune response of patients with cutaneous T-cell lymphoma: synergy with interferon-gamma enhances production of interleukin-12.
PMID 18021470·Clin Lymphoma Myeloma·2007
8-other
Early and delayed benefits of HIV-1 suppression: timeline of recovery of innate immunity effector cells.
PMID 17255736·AIDS·2007
4-observational
NK cell lysis of HIV-1-infected autologous CD4 primary T cells: requirement for IFN-mediated NK activation by plasmacytoid dendritic cells.
PMID 17675468·J Immunol·2007
3-trial
Baseline viral load and immune activation determine the extent of reconstitution of innate immune effectors in HIV-1-infected subjects undergoing antiretroviral treatment.
PMID 17675528·J Immunol·2007
3-trial
HIV-1-specific CD4+ T cell responses in chronically HIV-1 infected blippers on antiretroviral therapy in relation to viral replication following treatment interruption.
PMID 16418802·J Clin Immunol·2006
2-rct
Advances in macrophage and dendritic cell biology in HIV-1 infection stress key understudied areas in infection, pathogenesis, and analysis of viral reservoirs.
PMID 16935944·J Leukoc Biol·2006
6-review
Microarray data on gene modulation by HIV-1 in immune cells: 2000-2006.
PMID 16940334·J Leukoc Biol·2006
6-review
IL-13 acutely augments HIV-specific and recall responses from HIV-1-infected subjects in vitro by modulating monocytes.
PMID 16210662·J Immunol·2005
8-other
Dendritic and natural killer cell subsets associated with stable or declining CD4+ cell counts in treated HIV-1-infected children.
PMID 15809903·J Infect Dis·2005
8-other
Flt3 ligand treatment reverses endotoxin tolerance-related immunoparalysis.
PMID 15905588·J Immunol·2005
7-preclinical
Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15.
PMID 15328153·Blood·2004
8-other
Randomized, controlled trial of therapy interruption in chronic HIV-1 infection.
PMID 15630469·PLoS Med·2004
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 383 AVE FD ROOSEVELT, THIRD FLOOR (HUMANA)
SAN JUAN, PR 00918 - Phone
- (787) 622-5886
Quick Facts
- NPI
- 1306040423
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile